Bristol Gate Capital Partners Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Bristol Gate Capital Partners reduced its stake in UnitedHealth Group Inc by 1.39% during the most recent quarter end. The investment management company now holds a total of 205,293 shares of UnitedHealth Group Inc which is valued at $26.5 Million after selling 2,889 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on May 11, 2016.UnitedHealth Group Inc makes up approximately 5.00% of Bristol Gate Capital Partners’s portfolio.

Other Hedge Funds, Including , Brown Advisory Securities reduced its stake in UNH by selling 229 shares or 5.46% in the most recent quarter. The Hedge Fund company now holds 3,967 shares of UNH which is valued at $511,743. UnitedHealth Group Inc makes up approx 0.17% of Brown Advisory Securities’s portfolio.South Dakota Investment Council reduced its stake in UNH by selling 45,650 shares or 5.66% in the most recent quarter. The Hedge Fund company now holds 760,494 shares of UNH which is valued at $100.4 Million. UnitedHealth Group Inc makes up approx 2.19% of South Dakota Investment Council’s portfolio.Aperio Group boosted its stake in UNH in the latest quarter, The investment management firm added 40,859 additional shares and now holds a total of 643,082 shares of UnitedHealth Group Inc which is valued at $84.7 Million. UnitedHealth Group Inc makes up approx 0.72% of Aperio Group’s portfolio.

UnitedHealth Group Inc opened for trading at $128.75 and hit $130.86 on the upside on Monday, eventually ending the session at $130.64, with a gain of 1.27% or 1.64 points. The heightened volatility saw the trading volume jump to 24,66,033 shares. Company has a market cap of $124,213 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.